Vice President, Translational Biology
Cambridge, MA
Seres Therapeutics
Vice President, Translational Biology
Seres Therapeutics
Program Lead, SER-155
Seres Therapeutics
Senior Scientist, Microbiome Sciences
Seres Therapeutics
Senior Director, Computational Microbiome Sciences
Broad Institute
Post Doctoral Researcher, Regev Lab
Harvard School of Public Health
Postdoctoral Fellow (Visiting Scientist)
Seres Therapeutics
Program Lead, SER-301 and SER-155
Broad Institute
Postdoctoral Fellow
Seres Therapeutics
Director, Microbiome Sciences
Seres Therapeutics
Group Leader, Microbiome Sciences
William & Mary
Harvard University School of Public Health
